Vaxxa AB (FRA:7WA0) Beta: 10.7325 (As of Jun. 26, 2026)


FRA:7WA0 Vaxxa AB FRA:7WA0
22 GF Score
Price €0.03
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Vaxxa AB Beta?

Vaxxa AB FRA:7WA0 -4.91% 22 Beta is 10.7325 as of Jun. 26, 2026. GuruFocus rates FRA:7WA0 with a GF Score™ of 22/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Vaxxa AB's Beta is 10.7325.


Vaxxa AB  (FRA:7WA0) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Vaxxa AB Beta Related Terms


Vaxxa AB Beta Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB Beta Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.03 -4.61

Vaxxa AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.67 7.65 6.81 -4.61 10.13

FRA:7WA0 vs CRM, SHOP, UBER: Beta Comparison

For the Software - Application subindustry, Vaxxa AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxa AB Beta vs Software Industry

For the Software industry and Technology sector, Vaxxa AB's Beta distribution charts can be found below:

* The bar in red indicates where Vaxxa AB's Beta falls into.


FRA:7WA0
22GF Score
Vaxxa AB FRA:7WA0
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxxa AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 10.7325 mean?
Vaxxa AB (FRA:7WA0) has a Beta of 10.7325 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vaxxa AB and its competitors.
Is Vaxxa AB's Beta too high?
Vaxxa AB's current Beta is 10.7325. Overall, Vaxxa AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's Beta compare to CRM and SHOP?
Vaxxa AB's Beta of 10.7325 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Software company?
A good Beta depends on the Software industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vaxxa AB and its competitors. Vaxxa AB's current Beta is 10.7325. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current Beta of 10.7325. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 38% below its estimated fair value. The current Beta is 10.7325. Vaxxa AB's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current Beta is 10.7325 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of €0.03 is trading 38% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:7WA0:

  • Beta: 10.7325
  • GF Value™: €0.05 vs. price of €0.03 (38% below fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxxa AB Business Description

Other Exchanges VAXXA:Sweden
Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
22GF Score

Get the complete analysis for FRA:7WA0

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.05
GF Value